STOCK TITAN

Director John A. Ornell receives 4,520 RSUs at Bruker (BRKR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BRUKER CORP director John A. Ornell received an equity grant of 4,520 shares of Common Stock in the form of restricted stock units. The award was reported at no cash purchase price and increased his directly held stake to 39,732 shares after the transaction.

The RSUs will vest in a single installment on February 15, 2027. On that vesting date, each restricted stock unit will automatically convert into one share of Bruker common stock, aligning the director’s compensation with future company performance over the vesting period.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ORNELL JOHN A

(Last) (First) (Middle)
BRUKER CORPORATION
40 MANNING ROAD

(Street)
BILLERICA MA 01821

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/15/2026 A 4,520(1) A $0 39,732 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
/s/ Michael Simone, Attorney-in-Fact 02/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BRKR director John A. Ornell report?

John A. Ornell reported an equity grant of 4,520 shares of BRUKER CORP Common Stock as a restricted stock unit award. This increased his directly held position to 39,732 shares immediately following the reported transaction.

How many RSUs did John A. Ornell receive from BRKR?

John A. Ornell received 4,520 restricted stock units linked to BRUKER CORP Common Stock. These units represent a right to receive an equal number of common shares once the vesting conditions are satisfied on the specified vesting date.

When do John A. Ornell’s BRKR RSUs vest?

The RSUs granted to John A. Ornell vest in one installment on February 15, 2027. On that date, each restricted stock unit will automatically convert into one share of BRUKER CORP Common Stock, assuming continued satisfaction of applicable vesting conditions.

Did John A. Ornell buy BRKR shares on the open market?

No, the Form 4 shows a grant coded as an award acquisition, not an open-market purchase. The 4,520-share position was granted as restricted stock units at a reported price of $0.00 per share, reflecting compensatory equity rather than a cash transaction.

What is John A. Ornell’s BRKR shareholding after this grant?

Following the reported grant, John A. Ornell directly holds 39,732 shares of BRUKER CORP Common Stock. This total includes the newly awarded 4,520-share restricted stock unit grant once it is reflected as common stock upon vesting.

How will the BRKR RSUs reported by John A. Ornell settle?

Each RSU will settle into one share of BRUKER CORP Common Stock on February 15, 2027. Upon vesting, the restricted stock units automatically convert, delivering an equivalent number of common shares without the need for a separate purchase transaction.
Bruker Corp

NASDAQ:BRKR

View BRKR Stock Overview

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

5.45B
103.04M
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA